Russell Investments Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-330,680
| Closed | -$17.5M | – | 3288 |
|
|
2020
Q3 | $17.5M | Sell |
330,680
-96,750
| -23% | -$5.97M | 0.04% | 532 |
|
|
2020
Q2 | $26.2M | Buy |
427,430
+46,997
| +12% | +$2.72M | 0.06% | 368 |
|
|
2020
Q1 | $21.5M | Buy |
380,433
+220,409
| +138% | +$12.6M | 0.06% | 371 |
|
|
2019
Q4 | $9.11M | Buy |
160,024
+106,341
| +198% | +$5.64M | 0.02% | 898 |
|
|
2019
Q3 | $2.88M | Buy |
53,683
+37,212
| +226% | +$2.17M | 0.01% | 1494 |
|
|
2019
Q2 | $983K | Sell |
16,471
-2,108
| -11% | -$133K | ﹤0.01% | 1999 |
|
|
2019
Q1 | $1.16M | Sell |
18,579
-5,679
| -23% | -$376K | ﹤0.01% | 1991 |
|
|
2018
Q4 | $1.47M | Buy |
24,258
+5,004
| +26% | +$299K | ﹤0.01% | 1749 |
|
|
2018
Q3 | $1.13M | Sell |
19,254
-6,663
| -26% | -$340K | ﹤0.01% | 2049 |
|
|
2018
Q2 | $1.16M | Buy |
25,917
+16,177
| +166% | +$696K | ﹤0.01% | 2040 |
|
|
2018
Q1 | $431K | Buy |
9,740
+8,423
| +640% | +$354K | ﹤0.01% | 2515 |
|
|
2017
Q4 | $57K | Sell |
1,317
-3,801
| -74% | -$171K | ﹤0.01% | 2853 |
|
|
2017
Q3 | $238K | Sell |
5,118
-29,148
| -85% | -$1.4M | ﹤0.01% | 2635 |
|
|
2017
Q2 | $1.7M | Sell |
34,266
-185
| -0.5% | -$9.69K | ﹤0.01% | 1824 |
|
|
2017
Q1 | $1.89M | Buy |
34,451
+4,171
| +14% | +$221K | ﹤0.01% | 1785 |
|
|
2016
Q4 | $1.66M | Buy |
+30,280
| New | +$1.46M | ﹤0.01% | 1904 |
|
Other funds holding BSTC
Russell Investments Group's BSTC Position: Q4 2020 in Review
Russell Investments Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 330,680 shares — an estimated $17.5M sold.
Russell Investments Group first reported a position in BSTC in Q4 2016 and held it in 16 quarters. The position peaked at $26.2M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Russell Investments Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Russell Investments Group sold 330,680 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $17.5M.
- Russell Investments Group first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and held it in 16 quarters.
- Russell Investments Group's BioSpecifics Technologies Corp. position peaked at $26.2M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.